Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer

“…7 Also, the multidisciplinary remote pharmaceutical care software trialled for patients with congenital coagulopathy significantly improved the compliance of patients with drug treatment and also won unanimous praise from people from all walks of life. 8 In addition, the evaluation tool for drug-related consultation developed by Middleton et al 9 provides a basic guarantee for realisation of the concept of high-quality people-oriented pharmaceutical care. The application of wearable medical devices based on mobile devices is becoming more and more common, and provides a new paradigm for medical personnel to accurately observe and evaluate the condition.…”

“…For example, during the COVID-19 pandemic, many countries allowed the use of generic or treatment alternative medicines and implemented virtual medical consultations and electronic prescriptions. [24][25][26] Hospital pharmacists have taken advantage of cross-departmental and multidisciplinary collaboration to educate and manage the disease status of patients, 27 use remote medication procedures to monitor and guide patients' medication, 8 and conduct cognitive screening for elderly patients with metabolic diseases to eliminate hidden dangers of medication. 29 Different levels of graded pharmaceutical care measures are implemented at different stages of the disease, 30 which can identify and intervene in drug-related problems in a timely manner in the treatment of COPD and other diseases.…”

“…In recent years, in order to reduce the incidence of adverse drug reactions and to improve the prognosis and satisfaction of patients, the patient-centred pharmaceutical care model has gradually replaced the drug-centred product service model—for example, a seamless collaboration between general practitioners and community pharmacists during oral antineoplastic drug therapy 7. Also, the multidisciplinary remote pharmaceutical care software trialled for patients with congenital coagulopathy significantly improved the compliance of patients with drug treatment and also won unanimous praise from people from all walks of life 8. In addition, the evaluation tool for drug-related consultation developed by Middleton et al 9 provides a basic guarantee for realisation of the concept of high-quality people-oriented pharmaceutical care.…”